We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CLDI market cap is 9.68M. The company's latest EPS is USD -0.5737 and P/E is -0.31.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.04M | -2.03M | -1.5M | -15.65M | -9.82M |
| Net Income | -2.59M | -2.23M | -4.27M | -14.49M | -8.23M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -1.78M | -3.04M | -28.99M |
| Net Income | 3.39M | 3.53M | -29.22M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 42.86M | 43.18M | 44.01M | 18.59M | 10.02M |
| Total Liabilities | 5.61M | 8.15M | 12.77M | 19.68M | 18.25M |
| Total Equity | -5.21M | -7.88M | -11.97M | -1.09M | -8.24M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 231.77M | 42.86M | 10.02M |
| Total Liabilities | 16.45M | 5.61M | 18.25M |
| Total Equity | -14.69M | -5.21M | -8.24M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | 98k | 192k | 573k | -21.8M | -26.98M |
| Investing | 187.69M | -426k | -720k | -443k | -478k |
| Financing | -188.75M | 223k | 723k | 32M | 29.04M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.08M | 98k | -26.98M |
| Investing | -230M | 187.69M | -478k |
| Financing | 232.15M | -188.75M | 29.04M |
| Market Cap | 9.68M |
| Price to Earnings Ratio | -0.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.7 |
| Price to Book Ratio | -1.11 |
| Dividend Yield | - |
| Shares Outstanding | 50.92M |
| Average Volume (1 week) | 1.02M |
| Average Volume (1 Month) | 3.72M |
| 52 Week Change | -95.79% |
| 52 Week High | 5.00 |
| 52 Week Low | 0.1435 |
| Spread (Intraday) | 0.01 (4.84%) |
| Company Name | Calidi Biotherapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.calidibio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
